BioSight
Companies
Minerva Neurosciences, Inc. logo

NERV

NASDAQBURLINGTON, MA
Minerva Neurosciences, Inc.

Minerva Neurosciences is a clinical-stage neuroscience company focused on developing small molecule therapeutics for central nervous system disorders. The company's lead program is roluperidone, a clinical-stage small molecule in development for psychiatric and neurological indications.

Price history not yet available for NERV.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar